HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luis Manso Selected Research

nintedanib

3/2017Critically short telomeres and toxicity of chemotherapy in early breast cancer.
3/201718F-fluoromisonidazole PET and Activity of Neoadjuvant Nintedanib in Early HER2-Negative Breast Cancer: A Window-of-Opportunity Randomized Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Luis Manso Research Topics

Disease

34Breast Neoplasms (Breast Cancer)
05/2024 - 09/2013
19Neoplasms (Cancer)
12/2023 - 09/2006
10Ovarian Neoplasms (Ovarian Cancer)
12/2023 - 01/2018
5Triple Negative Breast Neoplasms
04/2023 - 11/2015
4Neoplasm Metastasis (Metastasis)
05/2024 - 11/2014
3Disease Progression
12/2023 - 01/2021
2Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2023 - 01/2021
2Adenocarcinoma
12/2023 - 01/2021
2Carcinoma (Carcinomatosis)
10/2023 - 01/2018
2Asthenia
01/2023 - 01/2019
2Fatigue
01/2023 - 03/2017
2Leukopenia
01/2019 - 11/2017
2Neutropenia
01/2019 - 11/2017
2Asthma (Bronchial Asthma)
06/2011 - 05/2011
1Adenosquamous Carcinoma
12/2023
1Arthralgia (Joint Pain)
12/2023
1Exanthema (Rash)
12/2023
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2023
1Fever (Fevers)
12/2023
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2023
1Stomach Neoplasms (Stomach Cancer)
10/2023
1Endometrial Neoplasms (Endometrial Cancer)
10/2023
1Ovarian Epithelial Carcinoma
01/2023
1Body Weight (Weight, Body)
01/2023
1Genomic Instability
01/2023
1Circulating Neoplastic Cells
01/2021
1Septic Shock (Toxic Shock Syndrome)
01/2021
1Fallopian Tube Neoplasms
02/2019
1Respiratory Tract Infections (Respiratory Tract Infection)
01/2019
1Febrile Neutropenia
01/2019
1Alopecia (Baldness)
01/2019
1Diarrhea
11/2017

Drug/Important Bio-Agent (IBA)

12Hormones (Hormone)IBA
10/2023 - 09/2013
9Bevacizumab (Avastin)FDA Link
12/2023 - 01/2018
8PlatinumIBA
12/2023 - 01/2018
7Biomarkers (Surrogate Marker)IBA
10/2023 - 01/2019
5olaparibIBA
12/2023 - 02/2019
5Paclitaxel (Taxol)FDA LinkGeneric
12/2023 - 11/2015
5Phenobarbital (Luminal)FDA Link
12/2021 - 09/2013
5ErbB Receptors (EGF Receptor)IBA
04/2021 - 10/2014
5Trastuzumab (Herceptin)FDA Link
11/2020 - 01/2014
4Poly(ADP-ribose) Polymerase InhibitorsIBA
08/2023 - 11/2020
4human ERBB2 proteinIBA
01/2019 - 10/2014
3Aromatase InhibitorsIBA
05/2024 - 06/2014
3EverolimusFDA Link
05/2024 - 09/2013
3eribulinFDA Link
10/2021 - 01/2018
3Fulvestrant (Faslodex)FDA Link
04/2021 - 06/2014
3abemaciclibIBA
04/2021 - 11/2017
3palbociclibIBA
12/2020 - 11/2020
3Estrogen ReceptorsIBA
03/2017 - 06/2014
2Cisplatin (Platino)FDA LinkGeneric
12/2023 - 09/2006
2Carboplatin (JM8)FDA LinkGeneric
12/2023 - 11/2015
2Immune Checkpoint InhibitorsIBA
10/2023 - 11/2020
2rucaparibIBA
08/2023 - 11/2022
2niraparibIBA
01/2023 - 10/2021
2GemcitabineFDA Link
10/2021 - 11/2015
2Anastrozole (Arimidex)FDA LinkGeneric
04/2021 - 06/2014
2AnthracyclinesIBA
11/2020 - 01/2019
2Lapatinib (GW572016)FDA Link
01/2020 - 10/2014
2Phosphotransferases (Kinase)IBA
01/2018 - 03/2017
2nintedanibIBA
03/2017 - 03/2017
1atezolizumabIBA
12/2023
1Immunoconjugates (Immunoconjugate)IBA
10/2023
1Epidermal Growth Factor (EGF)IBA
10/2023
1trastuzumab deruxtecanIBA
10/2023
1Ribosomal Protein S6 Kinases (S6 Kinase)IBA
04/2023
170-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA
04/2023
1Angiogenesis InhibitorsIBA
01/2023
1tetrachloroisophthalonitrile (Bravo)IBA
10/2021
1Capecitabine (Xeloda)FDA Link
10/2021
1Vinorelbine (Navelbine)FDA LinkGeneric
10/2021
1Letrozole (Femara)FDA LinkGeneric
04/2021
1tisotumab vedotinIBA
01/2021
1durvalumabIBA
11/2020
1ribociclibIBA
11/2020
1taxaneIBA
11/2020
1ME-344IBA
01/2020
1130-nm albumin-bound paclitaxelIBA
11/2019
1SolventsIBA
11/2019
12-(4-toluidino)-6-naphthalenesulfonic acid (TNS)IBA
11/2019
11-dodecylpyridoxal (PLD)IBA
02/2019
1polyadenosineIBA
02/2019
1Diphosphates (Pyrophosphates)IBA
02/2019
1Ribose (D-Ribose)IBA
02/2019
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
02/2019
1liposomal doxorubicin (Doxil)FDA Link
02/2019
1Taxoids (Taxanes)IBA
01/2019
1Proteins (Proteins, Gene)FDA Link
01/2019
1TransferasesIBA
01/2019
1Ado-Trastuzumab EmtansineIBA
08/2018
1balixafortideIBA
01/2018
1Cyclin-Dependent Kinase 4IBA
11/2017

Therapy/Procedure

29Therapeutics
05/2024 - 09/2013
13Drug Therapy (Chemotherapy)
05/2024 - 03/2017
3Neoadjuvant Therapy
08/2023 - 11/2015
2Drug Tapering
01/2023 - 01/2017
1Cytoreduction Surgical Procedures
08/2023
1Oncolytic Virotherapy
05/2022
1Immunotherapy
05/2022
1Adjuvant Chemotherapy
10/2021